www.cnbc.com
The medicine developed by the100-year old Danish drugmaker may impact patients’ brains in surprising ways
Read More
Novo Nordisk's 'long game' on weight loss drugs sparks hope in science, but the Street is impatient
By Elsa Ohlen
By Elsa Ohlen
